The NLRP3 inflammasome and COVID-19: Activation, pathogenesis and therapeutic strategies

N Zhao, B Di, L Xu - Cytokine & growth factor reviews, 2021 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), exhibits a wide spectrum of clinical presentations …

Bruton's tyrosine kinase inhibitors (BTKIs): review of preclinical studies and evaluation of clinical trials

D Rozkiewicz, JM Hermanowicz, I Kwiatkowska… - Molecules, 2023 - mdpi.com
In the last few decades, there has been a growing interest in Bruton's tyrosine kinase (BTK)
and the compounds that target it. BTK is a downstream mediator of the B-cell receptor (BCR) …

[HTML][HTML] NF-κB signaling and inflammation—drug repurposing to treat inflammatory disorders?

A Roberti, LE Chaffey, DR Greaves - Biology, 2022 - mdpi.com
Simple Summary Since its first description 35 years ago, the transcription factor NF-κB
(nuclear factor κ-light-chain-enhancer of activated B cells) has been shown to be a key …

NLRP3 inflammasome: the stormy link between obesity and COVID-19

A Lopez-Reyes, C Martinez-Armenta… - Frontiers in …, 2020 - frontiersin.org
Several countries around the world have faced an important obesity challenge for the past
four decades as the result of an obesogenic environment. This disease has a multifactorial …

[HTML][HTML] NLRP3 inflammasome/pyroptosis: a key driving force in diabetic cardiomyopathy

L Zhang, C Ai, M Bai, J Niu, Z Zhang - International Journal of Molecular …, 2022 - mdpi.com
Diabetic cardiomyopathy (DCM), a serious diabetic complication, is a kind of low-grade
inflammatory cardiovascular disorder. Due to the high risk of morbidity and mortality, DCM …

NLRP3 inflammasome activation after ischemic stroke

PP Han, Y Han, XY Shen, ZK Gao, X Bi - Behavioural brain research, 2023 - Elsevier
Cerebral ischemia is a pathological condition resulting from the cessation or reduction of
blood supply to the cerebral arteries. Neurological deficits that are clinically relevant can …

Natural products in attenuating renal inflammation via inhibiting the NLRP3 inflammasome in diabetic kidney disease

Y Wang, Z Sui, M Wang, P Liu - Frontiers in Immunology, 2023 - frontiersin.org
Diabetic kidney disease (DKD) is a prevalent and severe complications of diabetes and
serves as the primary cause of end-stage kidney disease (ESKD) globally. Increasing …

Multifaceted immunomodulatory effects of the BTK inhibitors ibrutinib and acalabrutinib on different immune cell subsets–beyond B lymphocytes

S Zhu, S Gokhale, J Jung, E Spirollari, J Tsai… - Frontiers in cell and …, 2021 - frontiersin.org
The clinical success of the two BTK inhibitors, ibrutinib and acalabrutinib, represents a major
breakthrough in the treatment of chronic lymphocytic leukemia (CLL) and has also …

BTK operates a phospho-tyrosine switch to regulate NLRP3 inflammasome activity

ZA Bittner, X Liu, M Mateo Tortola… - Journal of Experimental …, 2021 - rupress.org
Activity of the NLRP3 inflammasome, a critical mediator of inflammation, is controlled by
accessory proteins, posttranslational modifications, cellular localization, and …

Zanubrutinib ameliorates lipopolysaccharide-induced acute lung injury via regulating macrophage polarization

X Li, Y Wei, S Li, J Liang, Z Liu, Y Cui, J Gao… - International …, 2022 - Elsevier
Acute lung injury (ALI) is a disease characterized by pulmonary diffusion dysfunction and its
exacerbation stage is acute respiratory distress syndrome (ARDS), which may develop to …